ll have a profound social and economic impact on Turkey, we believe that the following actions are necessary to address this growing health challenge in Turkey.!
! We support increased Investment in, and the strengthening of, primary health care to ensure the delivery of a package of preventive and curative care interventions for chronic diseases at the primary care level to ensure access for the poor and vulnerable populations. ! We endorse the development of sustainable mechanisms, including surveillance and measurement of patient satisfaction, to monitor and evaluate the medical and economic consequences of the impact of interventions in a systematic and ongoing manner. ! We promote and support research studies on healthcare services, medical and social research as well as any kind of cooperation and collaboration for prevention and control of chronic diseases. ! We encourage building capacity of the health workforce, both in terms of reaching a sufficient quantity, as well as possessing appropriate qualities such as adequate knowledge, skills and competency, having constructive attitudes and humanitarian values, including those working in public and private sectors and also the community-based health workers, for prevention and control of chronic diseases. ! We request the activities for ensuring public awareness on, and for protection and use of national and international patient rights to be considered in a participative approach. ! We support establishment of a structure which would assess the current stage reached in prevention and management of chronic diseases based on quality, health results and patient satisfaction. ! We support creation of platforms where all stakeholders can act together regarding chronic diseases during implementation of the foregoing items. ! We call for an increased legal support for chronic disease patients who are able and willing to work to help them maintain their jobs. We need to help patients maintain their work and social life. ! We support measures aimed at reducing barriers that inhibit patient access to treatments for chronic diseases. Timely access to medicines, in the right dose and method, which have their effectiveness and safety proved globally is critical to the management and control of chronic diseases.